Efficacy and tolerability of BP-C1 in metastatic breast cancer: A Phase II, randomized, double-blind, and placebo-controlled Thai multi-center study
© 2019 Butthongkomvong et al. Aims: The aim of this study was to compare the efficacy and tolerability of BP-C1 vs equallooking placebo in metastatic breast cancer. Materials and methods: A randomized, double-blind, placebo-controlled multi-center study with a semicross-over design was performed. Si...
Saved in:
Main Authors: | Kritiya Butthongkomvong, Nilubol Raunroadroong, Sirikul Sorrarichingchai, Isaraporn Sangsaikae, Vichien Srimuninnimit, Henrik Harling, Stig Larsen |
---|---|
Other Authors: | Bispebjerg Hospital |
Format: | Article |
Published: |
2020
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/52380 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
BP-C1 in the treatment of patients with stage IV breast cancer: A randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase
by: Stig Larsen, et al.
Published: (2018) -
An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome
by: Wagner, A., et al.
Published: (2014) -
Trihydroxyethylrutosides in the treatment of hemorrhoids of pregnancy: A double-blind placebo-controlled trial
by: Vitaya Titapant, et al.
Published: (2018) -
Fansimef for prophylaxis of malaria: A double-blind randomized placebo controlled trial
by: D. Bunnag, et al.
Published: (2018) -
A double-blind placebo-controlled study of emtricitabine in chronic hepatitis B
by: Lim, S.G., et al.
Published: (2011)